Ultragenyx releases 2025 impact report outlining ESG progress across six pillars

Ultragenyx Pharmaceutical, Inc.

Ultragenyx Pharmaceutical, Inc.

RARE

0.00
  • Ultragenyx released its 2025 Impact Report, outlining ESG performance across innovation, patients, people, communities, planet, governance.
  • R&D represented about 62% of operating expenses, with five investigational therapies in pivotal programs across more than 160 trial sites.
  • Expanded access programs supported more than 700 patients across 50 countries since 2013.
  • Environmental actions included purchasing about 100% renewable electricity for two US sites, alongside waste diversion and climate risk assessment work.
  • Community spending included about $3.3 million in charitable donations, medical education, health-related grants across more than 20 countries.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief on July 08, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.